JP5414966B2 - 用時調製が可能なゼリー状医薬品 - Google Patents
用時調製が可能なゼリー状医薬品 Download PDFInfo
- Publication number
- JP5414966B2 JP5414966B2 JP2006214863A JP2006214863A JP5414966B2 JP 5414966 B2 JP5414966 B2 JP 5414966B2 JP 2006214863 A JP2006214863 A JP 2006214863A JP 2006214863 A JP2006214863 A JP 2006214863A JP 5414966 B2 JP5414966 B2 JP 5414966B2
- Authority
- JP
- Japan
- Prior art keywords
- water
- jelly
- time
- drug
- hot water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims description 55
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 73
- 235000015110 jellies Nutrition 0.000 claims description 46
- 239000008274 jelly Substances 0.000 claims description 46
- 229940079593 drug Drugs 0.000 claims description 45
- 239000000843 powder Substances 0.000 claims description 26
- 238000013268 sustained release Methods 0.000 claims description 16
- 239000012730 sustained-release form Substances 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000008187 granular material Substances 0.000 claims description 10
- 239000003349 gelling agent Substances 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 235000010987 pectin Nutrition 0.000 claims description 6
- 239000001814 pectin Substances 0.000 claims description 6
- 229920001277 pectin Polymers 0.000 claims description 6
- 235000010493 xanthan gum Nutrition 0.000 claims description 6
- 239000000230 xanthan gum Substances 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- 229940082509 xanthan gum Drugs 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 5
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 4
- 229920002907 Guar gum Polymers 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 4
- 235000010417 guar gum Nutrition 0.000 claims description 4
- 239000000665 guar gum Substances 0.000 claims description 4
- 229960002154 guar gum Drugs 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 235000010413 sodium alginate Nutrition 0.000 claims description 4
- 239000000661 sodium alginate Substances 0.000 claims description 4
- 229940005550 sodium alginate Drugs 0.000 claims description 4
- 239000003765 sweetening agent Substances 0.000 claims description 4
- 235000010491 tara gum Nutrition 0.000 claims description 4
- 239000000213 tara gum Substances 0.000 claims description 4
- 239000003002 pH adjusting agent Substances 0.000 claims description 3
- 229940127557 pharmaceutical product Drugs 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims 2
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- 238000010899 nucleation Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 26
- 229960005489 paracetamol Drugs 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 235000019658 bitter taste Nutrition 0.000 description 11
- 108010011485 Aspartame Proteins 0.000 description 10
- 239000000605 aspartame Substances 0.000 description 10
- 235000010357 aspartame Nutrition 0.000 description 10
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 10
- 229960003438 aspartame Drugs 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 8
- 235000010358 acesulfame potassium Nutrition 0.000 description 8
- 229960004998 acesulfame potassium Drugs 0.000 description 8
- 239000000619 acesulfame-K Substances 0.000 description 8
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 7
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 238000007922 dissolution test Methods 0.000 description 7
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 6
- NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 6
- 229940084026 sodium valproate Drugs 0.000 description 6
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 208000019505 Deglutition disease Diseases 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000000873 masking effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- 229960000292 pectin Drugs 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 239000000182 glucono-delta-lactone Substances 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011867 re-evaluation Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 210000000108 taste bud cell Anatomy 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
Description
用時調製のゼリー剤は以下のように調製した。なお、薬物としては苦みが強いことが知られているアセトアミノフェンを使用した。
アセトアミノフェン0.3g、ペクチン0.15g、粉末還元麦芽糖水アメ1.798g、クエン酸0.008g、フマル酸0.004g、第二リン酸カルシウム0.032g及びアスパルテーム0.008gを粉末の状態で良く混合したものをカップ容器に入れた。
アセトアミノフェン0.3g、キサンタンガム0.3g、タラガム0.1g、粉末還元麦芽糖水アメ1.3g、溶性デンプン1.3g、アスパルテーム0.2g及びアセスルファムカリウム0.032gを粉末の状態で良く混合したものをカップ容器に入れた。
アセトアミノフェン0.3g、キサンタンガム0.3g、グアガム0.1g、粉末還元麦芽糖水アメ1.3g、溶性デンプン1.3g、アスパルテーム0.2g及びアセスルファムカリウム0.032gを粉末の状態で良く混合したものをカップ容器に入れた。
アセトアミノフェン0.3g、カンテン0.1g、粉末還元麦芽糖水アメ2g、アスパルテーム0.2g及びアセスルファムカリウム0.032gを粉末の状態で良く混合したものをカップ容器に入れた。
アセトアミノフェン0.3g、ゼラチン0.2g、粉末還元麦芽糖水アメ1g、アスパルテーム0.2g及びアセスルファムカリウム0.032gを粉末の状態で良く混合したものをカップ容器に入れた。
本発明により得られた用時調製ゼリー剤が徐放性の機能を有することを明らかにするため、薬物として抗てんかん薬であるバルプロ酸ナトリウムの徐放性顆粒を選定し、実施例に倣い、ゼリー化した。これについて溶出試験を実施した。溶出試験の実施にあたっては、医療用医薬品 品質再評価に伴う品質情報集(オレンジブック)に公的溶出試験法として掲載されている、バルプロ酸ナトリウム徐放性顆粒の溶出試験法に準じて実施し、溶出試験結果の妥当性を評価した。
図1に示すように、用時調製ゼリー剤と徐放性顆粒製剤の溶出試験結果はほぼ同じであり、両製剤ともオレンジブックに記載されている溶出規格(溶出3時間後 溶出率15〜45%、溶出6時間後 溶出率35〜65%、溶出24時間後 溶出率75%以上)を満たしていた。このことから、本発明の用時調製ゼリー剤は、徐放性を有することが確認出来た。
Claims (3)
- 医薬品としての有効性を有する熱や水に弱い薬物をそのまま含有し、ペクチン、アルギン酸ナトリウム、キサンタンガムとタラガムの併用、キサンタンガムとグアガムの併用のいずれかのゲル化剤を用時調製時における水に対し1〜7重量%となるように含むことを特徴とする、使用時に温湯や加熱による溶解操作を経ず、また、冷却の操作も必要としない、加水のみで20〜90秒という短時間にゼリー状となる用時調製医薬品粉末(但し、継粉防止剤及び/又は結合剤を含有するものを除く)。
- 医薬品としての有効性を有する徐放性薬物をそのまま含有し、ペクチンを用時調製時における水に対し1〜7重量%となるように含むことを特徴とする、使用時に温湯や加熱による溶解操作を経ず、また、冷却の操作も必要としない、加水のみで20〜90秒という短時間に徐放性を有するゼリー状となる用時調製医薬品粉末(但し、継粉防止剤及び/又は結合剤を含有するものを除く)。
- 請求項1又は2に記載の粉末にpH調整剤及び甘味料から選択される添加剤を混合し、製造してなること、を特徴とする顆粒又は錠剤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006214863A JP5414966B2 (ja) | 2006-08-07 | 2006-08-07 | 用時調製が可能なゼリー状医薬品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006214863A JP5414966B2 (ja) | 2006-08-07 | 2006-08-07 | 用時調製が可能なゼリー状医薬品 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008037804A JP2008037804A (ja) | 2008-02-21 |
JP5414966B2 true JP5414966B2 (ja) | 2014-02-12 |
Family
ID=39173240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006214863A Active JP5414966B2 (ja) | 2006-08-07 | 2006-08-07 | 用時調製が可能なゼリー状医薬品 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5414966B2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5341601B2 (ja) * | 2008-04-22 | 2013-11-13 | 三栄源エフ・エフ・アイ株式会社 | 液状食品用ゲル化剤及びゲル状食品の製造方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK130287D0 (da) * | 1987-03-13 | 1987-03-13 | Benzon As Alfred | Oralt praeparat |
EP0662320B1 (en) * | 1991-08-30 | 2001-05-30 | Showa Yakuhin Kako Co., Ltd. | Dry gel composition |
JP4555407B2 (ja) * | 1998-05-06 | 2010-09-29 | 伊那食品工業株式会社 | 用時調製漢方・生薬製剤 |
JP2000103730A (ja) * | 1998-07-31 | 2000-04-11 | Otsuka Pharmaceut Co Ltd | 服用感が改善された医薬組成物 |
JP5046463B2 (ja) * | 2001-05-16 | 2012-10-10 | 大塚製薬株式会社 | 徐放性医薬組成物 |
JP3795365B2 (ja) * | 2001-09-28 | 2006-07-12 | 和光堂株式会社 | 服薬補助食品 |
JP3835544B2 (ja) * | 2002-09-10 | 2006-10-18 | 明治乳業株式会社 | ゼリー乾燥物 |
-
2006
- 2006-08-07 JP JP2006214863A patent/JP5414966B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2008037804A (ja) | 2008-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2302926T5 (es) | Cápsula blanda masticable | |
US6521257B1 (en) | Gelled compositions | |
JPH0460968B2 (ja) | ||
JP4264105B2 (ja) | イソソルビド含有ゼリー製剤 | |
JP2003104912A (ja) | 服薬補助食品 | |
JP2004099558A (ja) | 医薬用ゼリー組成物 | |
US20040028730A1 (en) | Process for preparing solid dosage forms for unpalatable pharmaceuticals | |
JP3835544B2 (ja) | ゼリー乾燥物 | |
JP5414966B2 (ja) | 用時調製が可能なゼリー状医薬品 | |
JP2006028028A (ja) | 経口医薬組成物 | |
JPH11228450A (ja) | 苦味等を隠蔽した経口薬剤 | |
KR102418840B1 (ko) | 겔 조성물 및 그 제조 방법 | |
JP5890110B2 (ja) | 可食性ゼリー状組成物、ゼリー状製剤及びゼリー状製剤の製造方法 | |
US7678817B2 (en) | Enteric medicinal composition for oral use | |
JP6365235B2 (ja) | 液状組成物 | |
JP2016138065A (ja) | 製剤及びその製造方法 | |
JP7418679B2 (ja) | 遅延性ゲル化組成物 | |
US4515805A (en) | Soluble sodium cromoglycate compositions | |
US20040072724A1 (en) | Gel preparation for internal use | |
JP2004099559A (ja) | 医薬用ゼリー組成物 | |
JP6515680B2 (ja) | スクラルファート含有液状組成物 | |
JP2011231051A (ja) | ビタミンb1類含有経口ゼリー剤 | |
JP2017214299A (ja) | 半固形製剤及びその製造方法 | |
JP6855732B2 (ja) | 粉体組成物及びその製造方法 | |
TW202327624A (zh) | 含有斯克拉非(Sucralfate)之凝膠狀醫藥組合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20081203 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120125 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120207 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120321 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120703 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120822 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20120823 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130507 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130802 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20130911 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131112 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131113 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5414966 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |